Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 524, pseudogene (RN7SL524P)

Target: RN7SL524P
Molecular classification: Processed pseudogene, Noncoding RNA

Overview

RNA, 7SL, cytoplasmic 524, pseudogene (RN7SL524P) is classified as a processed pseudogene, a type of noncoding RNA sequence that is homologous to the functional 7SL RNA gene, found within the human genome but believed to lack biological activity due to loss of function[1][2]. Unlike protein-coding genes or functional noncoding RNAs, RN7SL524P does not produce a functional molecule, nor does it participate in the canonical signal recognition particle pathways mediated by 7SL RNA. Most pseudogenes are considered genomic remnants, although some are transcribed and can act as regulators by contributing to the pool of noncoding RNAs involved in gene expression modulation, particularly in certain tissues or disease contexts[4]. There is no evidence that RN7SL524P is involved in pathogenic processes or serves as a biomarker or a pharmacological target.

Other names: RN7SL524PRNA, 7SL, cytoplasmic 524, pseudogene

Biological functions

None established (as a pseudogene, it does not produce a functional molecule with a direct biological role)General pseudogene functions can include potential regulation through small RNA production or acting as a microRNA decoy in some cases

Disease associations

None established for RN7SL524P directlySome pseudogenes are implicated in regulatory roles and disease, especially cancer, but there is no specific evidence for RN7SL524P

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 524, pseudogene (RN7SL524P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 524, pseudogene (RN7SL524P).

Explore the full profile